A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-03-06) →
What happened
Aminologics reported consolidated results for FY2025: revenue of US$15M (+31.1% year on year), operating profit of US$2.58M (from a loss a year earlier) and net income of US$2.68M (from a loss a year earlier).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$15M |
|---|---|
| Revenue vs a year earlier | +31.1% |
| Operating profit | US$2.58M |
| Net income | US$2.68M |
| Period | FY2025 (consolidated) |
| Filed | 2026-02-06, Change of 30% or more in revenue or profit/loss structure (15% for large companies) |
| Source | DART rcept 20260206901470 → open original filing |
Versions of this filing
- 2026-02-06Original (this page)
- 2026-03-06Amendment 1
Source: DART. Information only, not investment advice.